Eli Lilly Estimates $2.8B Q2 2026 Acquired IPR&D Charges, Impacting GAAP And Non-GAAP EPS By ~$3.02 Per Share

뉴스 본문을 불러오고 있어요.

Eli Lilly Estimates $2.8B Q2 2026 Acquired IPR&D Charges, Impacting GAAP And Non-GAAP EPS By ~$3.02 Per Share | 웨이프 WAPE

기사 요약